New guidelines have been developed for the treatment of schizophrenia through a collaborative effort of international experts from 30 countries. The recommendations are published in The Lancet Psychiatry journal.
Apr 3, 2025
0
0
A study by the Neuropsychopharmacology and IBeA groups of the University of the Basque Country (UPV/EHU) paves the way to obtaining biomarkers to predict the development of schizophrenia.
Mar 21, 2025
0
61
The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.
Mar 3, 2025
0
1
According to the dimensional view of mental disorders, psychosis is expressed on a continuum ranging from mild subclinical traits and experiences present in the general population (schizotypy) to clinical symptoms in patients ...
Feb 26, 2025
0
0
The symptoms of schizophrenia vary greatly from person to person. A new study appearing in the American Journal of Psychiatry shows how these differences manifest themselves in the structure of the brain.
Feb 26, 2025
0
107
Ben-Gurion University of the Negev's psychology researcher Prof. Florina Uzefovsky has developed a new concept she terms empathic disequilibrium, which she finds better explains social characteristics in a range of clinical ...
Feb 24, 2025
0
0
Schizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments exist, but they require an accurate diagnosis—something that is more challenging than one might ...
Feb 24, 2025
0
32
A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with the same mutation, a rare finding of a direct genetic link to psychosis, report researchers at ...
Feb 19, 2025
0
46
A new study investigated the brain circuits involved in psychosis—a condition characterized by delusions, hallucinations, disorganized thinking and detachment from reality.
Feb 12, 2025
0
3
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10% after cannabis legalization in Ontario, according to new research.
Feb 4, 2025
0
159
